EMBO New Venture Fellowship launched in memory of Suzanne Eaton
EMBO New Venture Fellowship supports early career scientists to explore alternative areas of research
Molly Stevens receives the FEBS | EMBO Women in Science Award 2021
EMBO and FEBS announce Molly Stevens of Imperial College London, UK, as the recipient of the FEBS | EMBO Women in Science Award 2021.
Innovating biomaterials and inspiring future generations of scientists
Molly Stevens, the 2021 recipient of the FEBS | EMBO Women in Science Award, talks to Kathy Weston about her unusual career choices, and her passion for using technology to address health inequality.
Bernd Pulverer appointed Chief Editor of EMBO Reports
EMBO Press announces the appointment of Bernd Pulverer, Head of Scientific Publishing at EMBO, as Chief Editor of EMBO Reports.
Facundo Batista appointed Chief Editor of The EMBO Journal
EMBO Press announces the appointment of immunologist Facundo Batista, PhD, as Chief Editor of The EMBO Journal.
EMBO Installation Grants support eight early-career scientists to establish independent laboratories
EMBO is pleased to announce the award of Installation Grants to eight scientists in the early stages of setting up their independent laboratories in Lithuania, Poland, Portugal and Turkey.
Embryonic environments: understanding neural crest cell migration
“One surprising answer leads to more questions,” says Elias Barriga.
Gene ends: how transcription termination shapes gene expression
Kinga Kamieniarz-Gdula’s career has shaped her approach to research and management.
DNA motor mechanics: exploring the biophysics of CRISPR
Algirdas Toleikis is excited about setting up his first independent research group in his home country.
SARS-CoV-2 infection demonstrated in a human lung bronchioalveolar tissue model
Development of an in vitro human-derived tissue model for studying virus infection and disease progression in the alveolar cells of the lungs responsible for oxygen and carbon dioxide exchange with the blood might enable the study of possible therapies for acute respiratory distress syndrome (ARDS) triggered by SARS-CoV-2.